251 related articles for article (PubMed ID: 15454089)
1. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.
Sutherland MK; Geoghegan JC; Yu C; Turcott E; Skonier JE; Winkler DG; Latham JA
Bone; 2004 Oct; 35(4):828-35. PubMed ID: 15454089
[TBL] [Abstract][Full Text] [Related]
2. Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.
Sutherland MK; Geoghegan JC; Yu C; Winkler DG; Latham JA
Bone; 2004 Aug; 35(2):448-54. PubMed ID: 15268896
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins and their antagonists: the sclerostin paradigm.
van Bezooijen RL; Papapoulos SE; Löwik CW
J Endocrinol Invest; 2005; 28(8 Suppl):15-7. PubMed ID: 16323824
[TBL] [Abstract][Full Text] [Related]
5. Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation.
van Bezooijen RL; Svensson JP; Eefting D; Visser A; van der Horst G; Karperien M; Quax PH; Vrieling H; Papapoulos SE; ten Dijke P; Löwik CW
J Bone Miner Res; 2007 Jan; 22(1):19-28. PubMed ID: 17032150
[TBL] [Abstract][Full Text] [Related]
6. High osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is associated with low apoptosis in C3H/HeJ osteoblasts.
Sheng MH; Lau KH; Mohan S; Baylink DJ; Wergedal JE
Calcif Tissue Int; 2006 May; 78(5):293-301. PubMed ID: 16604280
[TBL] [Abstract][Full Text] [Related]
7. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
Balemans W; Van Hul W
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
[TBL] [Abstract][Full Text] [Related]
8. The role of noggin in human mesenchymal stem cell differentiation.
Rifas L
J Cell Biochem; 2007 Mar; 100(4):824-34. PubMed ID: 17133353
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
10. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
11. SOST is a target gene for PTH in bone.
Keller H; Kneissel M
Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
[TBL] [Abstract][Full Text] [Related]
12. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells.
Lee SS; Sharma AR; Choi BS; Jung JS; Chang JD; Park S; Salvati EA; Purdue EP; Song DK; Nam JS
Biomaterials; 2012 Jun; 33(17):4251-63. PubMed ID: 22436801
[TBL] [Abstract][Full Text] [Related]
13. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
[TBL] [Abstract][Full Text] [Related]
14. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Nakagawa K; Imai Y; Ohta Y; Takaoka K
Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.
van Bezooijen RL; Roelen BA; Visser A; van der Wee-Pals L; de Wilt E; Karperien M; Hamersma H; Papapoulos SE; ten Dijke P; Löwik CW
J Exp Med; 2004 Mar; 199(6):805-14. PubMed ID: 15024046
[TBL] [Abstract][Full Text] [Related]
17. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.
Winkler DG; Sutherland MK; Geoghegan JC; Yu C; Hayes T; Skonier JE; Shpektor D; Jonas M; Kovacevich BR; Staehling-Hampton K; Appleby M; Brunkow ME; Latham JA
EMBO J; 2003 Dec; 22(23):6267-76. PubMed ID: 14633986
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
20. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
